Gary A. Abrams

Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial

Zobair M. Younossi, Vlad Ratziu, Rohit Loomba et al. · The Lancet · 2019 · 1.2K citations · Full text

Interim Analysis, Metabolic Associated Steatohepatitis, Hepatology +7

A Randomized, Double-Blinded, Placebo-Controlled Multicenter Trial of Etanercept in the Treatment of Alcoholic Hepatitis

Nicholas C. Boetticher, Craig J. Peine, Paul Y. Kwo et al. · Gastroenterology · 2008 · 330 citations · Full text

Substance Abuse, Hepatology, Viral Hepatitis +10

High fat diet induces dysregulation of hepatic oxygen gradients and mitochondrial function<i>in vivo</i>

Sudheer K. Mantena, Denty Paul Vaughn, Kelly K. Andringa et al. · Biochemical Journal · 2008 · 261 citations · Full text

Spectrum of NAFLD and Diagnostic Implications of the Proposed New Normal Range for Serum ALT in Obese Women *

Sachin Kunde, Audrey J. Lazenby, Ronald H. Clements et al. · Hepatology · 2005 · 209 citations · Full text

Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease

Gary A. Abrams, Sachin Kunde, Audrey J. Lazenby et al. · Hepatology · 2004 · 203 citations · Full text